Valuation : Middle East Pharmaceutical Industries Company

Market Cap 2.34B 623M 536M 504M 461M 862M 58.83B 864M 5.96B 2.31B 30.18B 2.29B 97.24B P/E 2024
30.5x
P/E 2025 22.9x
Enterprise Value 2.37B 631M 543M 511M 467M 873M 59.57B 875M 6.04B 2.34B 30.56B 2.32B 98.46B EV / Sales 2024
6.29x
EV / Sales 2025 4.89x
Free-Float
46.88%
Yield 2024
1.64%
Yield 2025 2.18%
1 day+0.22%
1 week+3.24%
Current month-1.69%
1 month+13.69%
3 months+13.50%
6 months+13.58%
Current year+5.20%
1 week 65.85
Extreme 65.85
68.1
1 month 58.6
Extreme 58.6
68.1
Current year 53.89
Extreme 53.885712
68.51
1 year 53.89
Extreme 53.885712
79.09
3 years 51.54
Extreme 51.542856
112.91
5 years 51.54
Extreme 51.542856
112.91
10 years 51.54
Extreme 51.542856
112.91
Manager TitleAgeSince
Chief Executive Officer 45 2018-09-04
Director of Finance/CFO - 2024-03-10
Chief Tech/Sci/R&D Officer 51 2022-12-31
Director TitleAgeSince
Chairman 54 2022-04-09
Director/Board Member 45 2023-09-12
Director/Board Member 45 2022-04-09
Change 5-day change 1-year change 3-year change Capi.($)
+0.22%+3.24%-6.93% - 623M
-0.89%-1.09%+19.16%+67.77% 48.26B
-1.72%-1.15%+45.80%+117.34% 40.5B
-0.70%-2.70%-10.84%+11.79% 11.85B
-2.01%-5.96%+10.47%+76.64% 11.83B
+2.31%0.00%+26.67%+153.33% 9.36B
+0.08%-4.11%+24.83%+43.80% 7.5B
-1.67%-0.35%+41.04%-11.59% 7.37B
-0.89%-3.09%+18.78%+207.82% 7.28B
-0.16%-2.36%-46.14%+16.28% 5.19B
Average -0.54%-1.56%+12.28%+75.91% 14.98B
Weighted average by Cap. -0.95%-1.69%+22.75%+82.78%

Financials

2024 2025
Net sales 394M 105M 90.29M 84.95M 77.6M 145M 9.91B 146M 1B 390M 5.08B 385M 16.37B 460M 123M 106M 99.28M 90.69M 170M 11.58B 170M 1.17B 455M 5.94B 450M 19.14B
Net income 79.85M 21.26M 18.3M 17.22M 15.73M 29.42M 2.01B 29.5M 203M 78.94M 1.03B 78.11M 3.32B 97.01M 25.83M 22.23M 20.92M 19.11M 35.74M 2.44B 35.84M 247M 95.91M 1.25B 94.89M 4.03B
Net Debt 42.83M 11.41M 9.82M 9.23M 8.44M 15.78M 1.08B 15.82M 109M 42.34M 553M 41.9M 1.78B 29.47M 7.85M 6.75M 6.35M 5.8M 10.86M 741M 10.89M 75.09M 29.14M 380M 28.83M 1.22B
Logo Middle East Pharmaceutical Industries Company
Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The Company develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
Employees
731
Date Price Change Volume
26-09-03 SAR 66.85 +0.22% 51,079
26-09-02 SAR 66.70 -1.62% 129,475
26-09-01 SAR 67.80 -0.29% 242,901
26-08-31 SAR 68.00 +4.45% 694,442
26-08-30 SAR 65.10 +0.54% 140,288
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
66.85SAR
Average target price
146.40SAR
Spread / Average Target
+119.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4016 Stock